ID   TLK2_HUMAN              Reviewed;         718 AA.
AC   Q86UE8-3;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   12-OCT-2022, entry version 188.
DE   RecName: Full=Isoform 3 of Serine/threonine-protein kinase tousled-like 2;
DE            EC=2.7.11.1;
DE   AltName: Full=HsHPK;
DE   AltName: Full=PKU-alpha;
DE   AltName: Full=Tousled-like kinase 2;
GN   Name=TLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT ARG-6, FUNCTION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000269|PubMed:9427565}, and Testis
RC   {ECO:0000269|PubMed:9427565};
RX   PubMed=9427565; DOI=10.1016/s0378-1119(97)00495-2;
RA   Yamakawa A., Kameoka Y., Hashimoto K., Yoshitake Y., Nishikawa K.,
RA   Tanihara K., Date T.;
RT   "cDNA cloning and chromosomal mapping of genes encoding novel protein
RT   kinases termed PKU-alpha and PKU-beta, which have nuclear localization
RT   signal.";
RL   Gene 202:193-201(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, MUTAGENESIS OF ASP-613,
RP   SUBCELLULAR LOCATION, INTERACTION WITH TLK1, AND ACTIVITY REGULATION.
RC   TISSUE=Placenta {ECO:0000269|PubMed:10523312};
RX   PubMed=10523312; DOI=10.1093/emboj/18.20.5691;
RA   Sillje H.H.W., Takahashi K., Tanaka K., Van Houwe G., Nigg E.A.;
RT   "Mammalian homologues of the plant tousled gene code for cell-cycle-
RT   regulated kinases with maximal activities linked to ongoing DNA
RT   replication.";
RL   EMBO J. 18:5691-5702(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-772 (ISOFORM 2/3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9662073; DOI=10.1007/bf02258367;
RA   Huang A.M., Chang T.J., Cho W.L., Chou C.K.;
RT   "From mosquito to man: identification of a novel protein kinase, HsHPK,
RT   which is highly expressed in human hepatoma tissues.";
RL   J. Biomed. Sci. 5:135-140(1998).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH YWHAZ.
RX   PubMed=10455159; DOI=10.1074/jbc.274.35.24865;
RA   Zhang S., Xing H., Muslin A.J.;
RT   "Nuclear localization of protein kinase U-alpha is regulated by 14-3-3.";
RL   J. Biol. Chem. 274:24865-24872(1999).
RN   [7]
RP   FUNCTION, INTERACTION WITH ASF1A AND ASF1B, AND MUTAGENESIS OF ASP-613.
RX   PubMed=11470414; DOI=10.1016/s0960-9822(01)00298-6;
RA   Sillje H.H.W., Nigg E.A.;
RT   "Identification of human Asf1 chromatin assembly factors as substrates of
RT   Tousled-like kinases.";
RL   Curr. Biol. 11:1068-1073(2001).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=12660173; DOI=10.1093/emboj/cdg151;
RA   Groth A., Lukas J., Nigg E.A., Sillje H.H.W., Wernstedt C., Bartek J.,
RA   Hansen K.;
RT   "Human tousled like kinases are targeted by an ATM- and Chk1-dependent DNA
RT   damage checkpoint.";
RL   EMBO J. 22:1676-1687(2003).
RN   [9]
RP   PHOSPHORYLATION AT SER-750, FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=12955071; DOI=10.1038/sj.onc.1206691;
RA   Krause D.R., Jonnalagadda J.C., Gatei M.H., Sillje H.H.W., Zhou B.-B.,
RA   Nigg E.A., Khanna K.;
RT   "Suppression of tousled-like kinase activity after DNA damage or
RT   replication block requires ATM, NBS1 and Chk1.";
RL   Oncogene 22:5927-5937(2003).
RN   [10]
RP   INTERACTION WITH FEZ1 AND FEZ2.
RX   PubMed=16484223; DOI=10.1074/jbc.m513280200;
RA   Assmann E.M., Alborghetti M.R., Camargo M.E.R., Kobarg J.;
RT   "FEZ1 dimerization and interaction with transcription regulatory proteins
RT   involves its coiled-coil region.";
RL   J. Biol. Chem. 281:9869-9881(2006).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94 AND SER-134, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   FUNCTION AS ASF1A AND ASF1B KINASE, AND ACTIVITY REGULATION.
RX   PubMed=20016786; DOI=10.1371/journal.pone.0008328;
RA   Pilyugin M., Demmers J., Verrijzer C.P., Karch F., Moshkin Y.M.;
RT   "Phosphorylation-mediated control of histone chaperone ASF1 levels by
RT   Tousled-like kinases.";
RL   PLoS ONE 4:E8328-E8328(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION.
RX   PubMed=22354037; DOI=10.1038/emboj.2012.36;
RA   McKnight N.C., Jefferies H.B., Alemu E.A., Saunders R.E., Howell M.,
RA   Johansen T., Tooze S.A.;
RT   "Genome-wide siRNA screen reveals amino acid starvation-induced autophagy
RT   requires SCOC and WAC.";
RL   EMBO J. 31:1931-1946(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73; SER-94; SER-99; SER-115;
RP   SER-117 AND SER-134, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-6; ASP-54; GLY-95; GLY-108; LEU-109;
RP   LEU-173 AND GLN-262.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [23]
RP   VARIANT MRD57 720-ARG--ASN-772 DEL, AND INVOLVEMENT IN MRD57.
RX   PubMed=27479843; DOI=10.1038/nn.4352;
RA   Lelieveld S.H., Reijnders M.R., Pfundt R., Yntema H.G., Kamsteeg E.J.,
RA   de Vries P., de Vries B.B., Willemsen M.H., Kleefstra T., Loehner K.,
RA   Vreeburg M., Stevens S.J., van der Burgt I., Bongers E.M., Stegmann A.P.,
RA   Rump P., Rinne T., Nelen M.R., Veltman J.A., Vissers L.E., Brunner H.G.,
RA   Gilissen C.;
RT   "Meta-analysis of 2,104 trios provides support for 10 new genes for
RT   intellectual disability.";
RL   Nat. Neurosci. 19:1194-1196(2016).
RN   [24]
RP   VARIANTS MRD57 13-GLN--ASN-772 DEL; 61-ARG--ASN-772 DEL; 68-GLU--ASN-772
RP   DEL; 259-TYR--ASN-772 DEL; 262-ARG--ASN-772 DEL; ASP-297; 303-ARG--ASN-772
RP   DEL; 330-SER--ASN-772 DEL; GLN-339; TRP-339; LYS-447; ARG-493; ARG-518;
RP   TRP-568; 573-GLN--ASN-772 DEL; ASN-629; ARG-680; 720-ARG--ASN-772 DEL AND
RP   746-ARG--ASN-772 DEL, AND INVOLVEMENT IN MRD57.
RX   PubMed=29861108; DOI=10.1016/j.ajhg.2018.04.014;
RG   Deciphering Developmental Disorders Study;
RA   Reijnders M.R.F., Miller K.A., Alvi M., Goos J.A.C., Lees M.M.,
RA   de Burca A., Henderson A., Kraus A., Mikat B., de Vries B.B.A., Isidor B.,
RA   Kerr B., Marcelis C., Schluth-Bolard C., Deshpande C., Ruivenkamp C.A.L.,
RA   Wieczorek D., Baralle D., Blair E.M., Engels H., Luedecke H.J., Eason J.,
RA   Santen G.W.E., Clayton-Smith J., Chandler K., Tatton-Brown K., Payne K.,
RA   Helbig K., Radtke K., Nugent K.M., Cremer K., Strom T.M., Bird L.M.,
RA   Sinnema M., Bitner-Glindzicz M., van Dooren M.F., Alders M., Koopmans M.,
RA   Brick L., Kozenko M., Harline M.L., Klaassens M., Steinraths M.,
RA   Cooper N.S., Edery P., Yap P., Terhal P.A., van der Spek P.J., Lakeman P.,
RA   Taylor R.L., Littlejohn R.O., Pfundt R., Mercimek-Andrews S.,
RA   Stegmann A.P.A., Kant S.G., McLean S., Joss S., Swagemakers S.M.A.,
RA   Douzgou S., Wall S.A., Kuery S., Calpena E., Koelling N., McGowan S.J.,
RA   Twigg S.R.F., Mathijssen I.M.J., Nellaker C., Brunner H.G., Wilkie A.O.M.;
RT   "De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and
RT   Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.";
RL   Am. J. Hum. Genet. 102:1195-1203(2018).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000305};
CC         IsoId=Q86UE8-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:10523312};
CC         IsoId=Q86UE8-2; Sequence=VSP_050573;
CC       Name=3 {ECO:0000269|PubMed:9427565};
CC         IsoId=Q86UE8-3; Sequence=VSP_050572, VSP_050573;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS45753.1; -.
DR   RefSeq; NP_001271292.1; NM_001284363.1.
DR   RefSeq; XP_016879540.1; XM_017024051.1.
DR   RefSeq; XP_016879542.1; XM_017024053.1.
DR   ProteomicsDB; 69813; -.
DR   Ensembl; ENST00000343388.11; ENSP00000340800.7; ENSG00000146872.19.
DR   Ensembl; ENST00000683104.1; ENSP00000508242.1; ENSG00000146872.19.
DR   Proteomes; UP000005640; Chromosome 17.
PE   1: Evidence at protein level;
SQ   SEQUENCE   718 AA;  82348 MW;  60E703322E8F2D2D CRC64;
     MMEELHSLDP RRQELLEARF TGVGVSKGPL NSESSNQSLC SVGSLSDKEV ETPEKKQNDQ
     RNRKRKAEPY ETSQGKGTPR GHKISDYFER RVEQPLYGLD GSAAKEATEE QSALPTLMSV
     MLAKPRLDTE QLAQRGAGLC FTFVSAQQNS PSSTGSGNTE HSCSSQKQIS IQHRQTQSDL
     TIEKISALEN SKNSDLEKKE GRIDDLLRAN CDLRRQIDEQ QKMLEKYKER LNRCVTMSKK
     LLIEKSKQEK MACRDKSMQD RLRLGHFTTV RHGASFTEQW TDGYAFQNLI KQQERINSQR
     EEIERQRKML AKRKPPAMGQ APPATNEQKQ RKSKTNGAEN ETLTLAEYHE QEEIFKLRLG
     HLKKEEAEIQ AELERLERVR NLHIRELKRI HNEDNSQFKD HPTLNDRYLL LHLLGRGGFS
     EVYKAFDLTE QRYVAVKIHQ LNKNWRDEKK ENYHKHACRE YRIHKELDHP RIVKLYDYFS
     LDTDSFCTVL EYCEGNDLDF YLKQHKLMSE KEARSIIMQI VNALKYLNEI KPPIIHYDLK
     PGNILLVNGT ACGEIKITDF GLSKIMDDDS YNSVDGMELT SQGAGTYWYL PPECFVVGKE
     PPKISNKVDV WSVGVIFYQC LYGRKPFGHN QSQQDILQEN TILKATEVQF PPKPVVTPEA
     KAFIRRCLAY RKEDRIDVQQ LACDPYLLPH IRKSVSTSSP AGAAIASTSG ASNNSSSN
//
